The Influence of Smoking and Co-morbidity on Dose Achievement in Primary or Adjuvant Radio(Chemo)Therapy in Head and Neck Squamous Cell Carcinoma (HNSCC)

The Influence of Smoking and Co-morbidity on Dose Achievement in Primary or Adjuvant Radio(Chemo)Therapy in Head and Neck Squamous Cell Carcinoma (HNSCC)

Introduction: Smoking has a negative impact on survival of HNSCC patients. In addition, smoking is associated with the prevalence of co-morbidities and, thus, it may be assumed that not smoking per se but co-morbidities impact the course of therapy in terms of lower compliance and dose-reduction. Ho...

Full description

Bibliographic Details
Main Authors: Asita Fazel, Elgar Susanne Quabius, Alexander Fabian, Thilo Schleicher, Konstantin Kress, Martin Laudien, Karen Huber, Arved Herzog, Mireia Gonzales Donate, Markus Hoffmann
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-03-01
Series:Frontiers in Oncology
Subjects:
co-morbidity
therapy compliance
dose achievement
smoking
radiochemotherapy
radiotherapy
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.00398/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2020.00398/full

Similar Items